StockNow
CalendarLog in
Politics

The US is reportedly considering allowing most pharmaceutical licensing deals with China, while limiting restrictions to deals involving pathogens

StockNow breaking-news AI analysis

The US is reportedly considering allowing most pharmaceutical licensing deals with China, limiting restrictions to pathogen-related transactions as the Treasury drafts rules amid industry lobbying.

News detail

The Treasury is drafting rules accordingly, while major pharmaceutical companies are lobbying against broader China investment restrictions

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

UKMTO has received a report of an incident in the Strait of Hormuz; The CSO of a vessel has reported a tanker being hit by an unknown projectile causing a fire, which was extinguished

Commodities

Saudis reportedly tells Europe oil refiners that they will get no crude next month

Politics

ECB President Lagarde says rates do not move in lockstep with energy prices, and that other factors play a role